Iwase S, Mano T, Saito M, Ishida G, Effect of a centrally-acting muscle relaxant, eperisone hydrochloride, on muscle sympathetic nerve activity in humans, in Functional Neurology, vol. 7, n. 6, 1992, pp. 459-70, PMID1338431.
Beltrame A, Grangiè S, Guerra L, Clinical experience with eperisone in the treatment of acute low back pain, in Minerva Medica, vol. 99, n. 4, agosto 2008, pp. 347-52, PMID18663343.
Morikawa K, Oshita M, Yamazaki M, Ohara N, Mizutani F, Kato H, Ito Y, Kontani H, Koshiura R, Pharmacological studies of the new centrally acting muscle relaxant 4'-ethyl-2-methyl-3-pyrrolidinopropiophenone hydrochloride, in Arzneimittel-Forschung, vol. 37, n. 3, marzo 1987, pp. 331-6, PMID3593447.
Novales-Li P, Sun XP, Takeuchi H, Suppression of calcium current in a snail neurone by eperisone and its analogues, in European Journal of Pharmacology, vol. 168, n. 3, settembre 1989, pp. 299-305, PMID2555204.
Mihara K, Matsumura M, Yoshioka E, Hanada K, Nakasa H, Ohmori S, Kitada M, Ogata H, Intestinal first-pass metabolism of eperisone in the rat, in Pharmaceutical Research, vol. 18, n. 8, agosto 2001, pp. 1131-7, PMID11587484.
Tariq M, Akhtar N, Ali M, Rao S, Badshah M, Irshad M, Eperisone compared to physiotherapy on muscular tone of stroke patients: a prospective randomized open study, in JPMA. the Journal of the Pakistan Medical Association, vol. 55, n. 5, maggio 2005, pp. 202-4, PMID15960286.